arrow
E

Esperanza B. Papadopoulos

memorial sloan kettering cancer center
H指数:52
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial

鲁索利替尼外用制剂治疗慢性皮肤移植物抗宿主病:一项单中心、随机、双盲、患者内对照的2期临床试验

2026-09-160
OAAI
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations

TP53突变携带的髓系恶性肿瘤中,移植后干预和慢性移植物抗宿主病对生存的影响

2026-04-120
PRE
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study

基于模型的抗胸腺细胞球蛋白剂量在体外CD34+选择的同种异基因造血细胞移植中的应用:一项单中心、单臂、II期研究

2025-12-010
PRE
Outcomes of terminal complement blockade in adults with high-risk transplant-associated thrombotic microangiopathy: a comparative analysis

高危移植相关血栓性微血管病成人中终末补体阻滞的结局:一项比较分析

2025-11-280
PRE
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort

异基因造血细胞移植在未达完全缓解的急性髓系白血病中的应用:当代队列的结局与预后因素

2025-11-250
OAAI
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients

与年龄相关、衰老相关分泌表型及同种异基因造血细胞移植在老年患者中的结局

2025-08-190
PRE
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

移植预处理、NPM1突变及FLT3-ITD急性髓系白血病中可测量的微小残留病的影响

2025-07-030
OAAI
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant

骨髓和血液显示出不同的免疫重建模式,并与移植后的复发存在关联。

2025-06-140
OAAI
Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients

莱特莫韦预防高危异基因造血干细胞移植受者巨细胞病毒复发

2025-02-010
PRE
Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
2024-10-280
OAAI
Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

接受异基因造血干细胞移植的非霍奇金淋巴瘤患者与非清髓性预处理相比,强度降低

2024-01-012
OAAI
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
2023-09-131
OAAI
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
2023-07-2613
OAAI
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
2023-05-1526
OAAI
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
2022-10-3115
OAAI
Racial disparities in access to alternative donor allografts persist in the era of donors for all
2022-10-1817
OAAI